{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:57:47Z","timestamp":1773781067086,"version":"3.50.1"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1003973","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T18:53:50Z","timestamp":1422989630000},"page":"e1003973","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial"],"prefix":"10.1371","volume":"11","author":[{"given":"Paul T.","family":"Edlefsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomer","family":"Hertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sodsai","family":"Tovanabutra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Gartland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan C.","family":"deCamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig A.","family":"Magaret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Gottardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Juraska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan B.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Sanders-Buell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Carrico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Menis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"RV144 Sequencing Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorachai","family":"Nitayaphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Punnee","family":"Pitisuttithum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaranit","family":"Kaewkungwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supachai","family":"Rerks-Ngarm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsiana","family":"Kirys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivelin S.","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Scheffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei L. Kosakovsky","family":"Pond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Schief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James I.","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0264-410X(98)00182-0","article-title":"Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1\/V2 domain of HIV-1 gp120","volume":"16","author":"A Pinter","year":"1998","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"228ra239","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1\u2013V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"NL Yates","year":"2014","journal-title":"Sci Transl Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e87572","DOI":"10.1371\/journal.pone.0087572","article-title":"Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection","volume":"9","author":"S Zolla-Pazner","year":"2014","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e75665","DOI":"10.1371\/journal.pone.0075665","article-title":"Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial","volume":"8","author":"R Gottardo","year":"2013","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature11519","article-title":"Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2","volume":"490","author":"M Rolland","year":"2012","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nm.2316","article-title":"Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial","volume":"17","author":"M Rolland","year":"2011","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e43396","DOI":"10.1371\/journal.pone.0043396","article-title":"MRKAd5 HIV-1 Gag\/Pol\/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load","volume":"7","author":"H Janes","year":"2012","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.1128\/JVI.01164-14","article-title":"Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial","volume":"88","author":"AJ Gartland","year":"2014","journal-title":"J Virol"},{"key":"ref11","unstructured":"Zolla-Pazner S, Williams C, Rolland M, Edlefsen PT, Gilbert PB, et al. (2014) IgG V3-specific antibody (Ab) reactivity in plasma from RV144: Implications for vaccine efficacy. Keystone Symposia: HIV Vaccines: Adaptive Immunity and Beyond (X3). Banff, Alberta, Canada."},{"key":"ref12","first-page":"41","article-title":"HIV-1 subtype and circulating recombinant form (CRF) reference sequences","volume":"2005","author":"T Leitner","year":"2005","journal-title":"HIV Sequence Compendium"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate\u2014a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society Series B-Methodological"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2307\/2532940","article-title":"Applying Cox regression to competing risks","volume":"51","author":"M Lunn","year":"1995","journal-title":"Biometrics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1002\/1097-0258(20001130)19:22<3065::AID-SIM600>3.0.CO;2-D","article-title":"Comparison of competing risks failure time methods and time-independent methods for assessing strain variations in vaccine protection","volume":"19","author":"PB Gilbert","year":"2000","journal-title":"Stat Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1371\/journal.pone.0000503","article-title":"HIV-specific probabilistic models of protein evolution","volume":"2","author":"DC Nickle","year":"2007","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1541-0420.2007.00845.x","article-title":"Genome scanning tests for comparing amino acid sequences between groups","volume":"64","author":"PB Gilbert","year":"2008","journal-title":"Biometrics"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Edlefsen PT (2014) Evaluating the dependence of a non-leaky intervention\u2019s partial efficacy on a categorical mark. arXiv:12066701v2.","DOI":"10.1155\/2014\/813789"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1467-9469.2011.00746.x","article-title":"Estimation of stratified mark-specific proportional hazards models with missing marks","volume":"39","author":"Y Sun","year":"2012","journal-title":"Scand Stat Theory Appl"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Gilbert PB, Sun Y (2014) Testing for vaccine efficacy against a spectrum of pathogen sequences in stratified mark-specific proportional hazards models with missing marks, with application to the RV144 HIV vaccine efficacy trial. Journal of the Royal Statistical Society, Series C, in press.","DOI":"10.1111\/rssc.12067"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-5193(86)80075-3","article-title":"The classification of amino acid conservation","volume":"119","author":"WR Taylor","year":"1986","journal-title":"J Theor Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1021\/jm00390a003","article-title":"Peptide quantitative structure-activity relationships, a multivariate approach","volume":"30","author":"S Hellberg","year":"1987","journal-title":"J Med Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm9700575","article-title":"New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids","volume":"41","author":"M Sandberg","year":"1998","journal-title":"J Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0003-2670(93)80437-P","article-title":"DNA and peptide sequences and chemical processes multivariately modeled by principal component analysis and partial least-squares projections to latent structures","volume":"277","author":"S Wold","year":"1993","journal-title":"Analytica Chimica Acta"},{"key":"ref25","unstructured":"Scheffler K, Kosakovsky SL PRIME. HyPhy Wiki, <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/hyphyorg\/w\/indexphp\/PRIME\" xlink:type=\"simple\">http:\/\/hyphyorg\/w\/indexphp\/PRIME<\/ext-link>."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ympev.2006.07.006","article-title":"Modeling amino acid substitution patterns in orthologous and paralogous genes","volume":"42","author":"GC Conant","year":"2007","journal-title":"Mol Phylogenet Evol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1245625","article-title":"Crystal structure of a soluble cleaved HIV-1 envelope trimer","volume":"342","author":"JP Julien","year":"2013","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1093\/bioinformatics\/btl255","article-title":"Learning MHC I\u2014peptide binding","volume":"22","author":"N Jojic","year":"2006","journal-title":"Bioinformatics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1371\/journal.pone.0000796","article-title":"NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence","volume":"2","author":"M Nielsen","year":"2007","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/infdis\/jis367","article-title":"Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials","volume":"206","author":"DC Montefiori","year":"2012","journal-title":"J Infect Dis"},{"key":"ref31","first-page":"177","article-title":"Analysis of the basis of resistance and susceptibility of CD4+ T cells to human immunodeficiency virus (HIV)-gp120 induced anergy","volume":"76","author":"A Faith","year":"1992","journal-title":"Immunology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","article-title":"Amino acid substitution matrices from protein blocks","volume":"89","author":"S Henikoff","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1089\/aid.2006.22.1014","article-title":"High incidence of unusual cysteine variants in gp120 envelope proteins from early HIV type 1 infections from a Phase 3 vaccine efficacy trial","volume":"22","author":"DV Jobes","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/glycob\/cwh106","article-title":"Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin","volume":"14","author":"M Zhang","year":"2004","journal-title":"Glycobiology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/1541-0420.00049","article-title":"Multiple outputation: inference for complex clustered data by averaging analyses from independent data","volume":"59","author":"D Follmann","year":"2003","journal-title":"Biometrics"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.immuni.2012.11.011","article-title":"Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2","volume":"38","author":"HX Liao","year":"2013","journal-title":"Immunity"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1128\/JVI.76.8.3852-3864.2002","article-title":"Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop","volume":"76","author":"NG Hoffman","year":"2002","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1128\/JVI.80.2.750-758.2006","article-title":"Human immunodeficiency virus type 1 coreceptor switching: V1\/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations","volume":"80","author":"C Pastore","year":"2006","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/nm.2985","article-title":"Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape","volume":"18","author":"PL Moore","year":"2012","journal-title":"Nat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e1000955","DOI":"10.1371\/journal.pcbi.1000955","article-title":"Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies","volume":"6","author":"S Gnanakaran","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.4049\/jimmunol.1102756","article-title":"The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope","volume":"188","author":"MS de Souza","year":"2012","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/422258","article-title":"Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults","volume":"190","author":"S Nitayaphan","year":"2004","journal-title":"J Infect Dis"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/35036559","article-title":"Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia","volume":"407","author":"TM Allen","year":"2000","journal-title":"Nature"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nm0910-981","article-title":"The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise","volume":"16","year":"2010","journal-title":"Nat Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"79ps13","DOI":"10.1126\/scitranslmed.3001863","article-title":"HIV-1 vaccines and adaptive trial designs","volume":"3","author":"L Corey","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2307\/2533835","article-title":"Statistical methods for assessing differential vaccine protection against human immunodeficiency virus types","volume":"54","author":"PB Gilbert","year":"1998","journal-title":"Biometrics"},{"key":"ref47","first-page":"512","article-title":"Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees","volume":"10","author":"K Tamura","year":"1993","journal-title":"Mol Biol Evol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/10635150390235520","article-title":"A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood","volume":"52","author":"S Guindon","year":"2003","journal-title":"Syst Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2144\/000113370","article-title":"DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites","volume":"48","author":"W Deng","year":"2010","journal-title":"Biotechniques"},{"key":"ref50","article-title":"R: a language and environment for statistical computing","year":"2014"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/3315826","article-title":"Practicing safe statistics with the mid-p","volume":"22","author":"RD Routledge","year":"1994","journal-title":"Canadian Journal of Statistics"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2307\/2530374","article-title":"The analysis of failure times in the presence of competing risks","volume":"34","author":"RL Prentice","year":"1978","journal-title":"Biometrics"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2013.06.001","article-title":"A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling","volume":"395","author":"GC Imholte","year":"2013","journal-title":"J Immunol Methods"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"X Wei","year":"2003","journal-title":"Nature"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e1000598","DOI":"10.1371\/journal.ppat.1000598","article-title":"Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection","volume":"5","author":"PL Moore","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"11502","DOI":"10.1128\/JVI.05363-11","article-title":"Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals","volume":"85","author":"GD Tomaras","year":"2011","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2567.2010.03268.x","article-title":"MHC class II epitope predictive algorithms","volume":"130","author":"M Nielsen","year":"2010","journal-title":"Immunology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1089\/aid.2005.21.1016","article-title":"Covariability of selected amino acid positions for HIV type 1 subtypes C and B","volume":"21","author":"PB Gilbert","year":"2005","journal-title":"AIDS Res Hum Retroviruses"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1004733","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1003973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:22:46Z","timestamp":1717719766000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1003973"}},"subtitle":[],"editor":[{"given":"Bjoern","family":"Peters","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1003973","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1004733","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}